22q11 DiGeorge Syndrome and depression

Individuals with 22q11 DiGeorge Syndrome have a significantly higher risk of developing mood disorders, including depression and anxiety, compared to the general population. This increased vulnerability is linked to both the underlying neurodevelopmental profile of 22q11 DiGeorge Syndrome and the chronic stress of managing a complex, multisystem condition.

Is there a link between 22q11 DiGeorge Syndrome and mental health?

Yes, there is a strong, well-documented connection. Research indicates that up to 30-40% of adolescents and adults with 22q11 DiGeorge Syndrome may experience clinically significant anxiety or depression. The genetic deletion on chromosome 22q11.2 impacts brain development, specifically affecting areas involved in emotional regulation and executive function. Furthermore, the biochemical pathways associated with this deletion may predispose individuals to neurochemical imbalances, making the diagnosis of 22q11 DiGeorge Syndrome a significant risk factor for psychiatric challenges throughout the lifespan.

What are the common emotional and psychological challenges?

Patients with 22q11 DiGeorge Syndrome often face a unique set of stressors that contribute to poor mental health, including:

• Social Anxiety: Difficulty with social cues and communication can lead to isolation.


• Chronic Fatigue and Pain: Managing multisystem symptoms leads to physical exhaustion, which frequently exacerbates depressive symptoms.


• Executive Dysfunction: Challenges with organization and planning can create a sense of being overwhelmed, fueling feelings of hopelessness.


• Developmental Delays: Navigating educational and workplace environments with cognitive or learning differences can impact self-esteem.

How can I recognize signs of depression in 22q11 DiGeorge Syndrome?

Recognizing depression in 22q11 DiGeorge Syndrome can be difficult because symptoms may overlap with other cognitive or physical challenges. Watch for persistent changes in behavior, such as withdrawal from hobbies, sleep disturbances, changes in appetite, or increased irritability. In the DiseaseMaps community, 215 people with 22q11 DiGeorge Syndrome have shared their experiences, often highlighting that "masked depression"—where the individual appears withdrawn or unusually quiet rather than overtly sad—is common.

What are the effective treatment options?

Treatment for depression in the context of 22q11 DiGeorge Syndrome requires a multidisciplinary approach:

1. Cognitive Behavioral Therapy (CBT): Tailored to the individual’s cognitive level, CBT can help manage anxiety and reframe negative thought patterns.


2. Acceptance and Commitment Therapy (ACT): Highly effective for those dealing with the chronic nature of 22q11 DiGeorge Syndrome, focusing on value-based living despite limitations.


3. Pharmacotherapy: Selective Serotonin Reuptake Inhibitors (SSRIs) are commonly prescribed, but must be managed by a psychiatrist familiar with the unique metabolic profile of 22q11 DiGeorge Syndrome.


4. Support Groups: Connecting with others via platforms like DiseaseMaps.org can reduce the isolation common in rare disease journeys.

Next steps

• Consult a psychiatrist who specializes in neurodevelopmental or genetic disorders to ensure any medication is appropriate for your specific clinical picture.


• Seek a therapist experienced in working with intellectual or developmental disabilities.


• If you or a loved one are in immediate distress, please call or text 988 in the U.S. and Canada, or contact your local emergency services immediately.


• Join the 215 members on DiseaseMaps.org to share coping strategies with others living with 22q11 DiGeorge Syndrome.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): 22q11.2 deletion syndrome


• Orphanet: 22q11.2 deletion syndrome


• The International 22q11.2 Society: Clinical guidelines for psychiatric care


• OMIM (Online Mendelian Inheritance in Man): DiGeorge Syndrome